The Macrophage-directed Therapies Summit is the only industry-focused meeting dedicated to advancing current CD47 and CAR-macrophage therapies alongside the new and exciting macrophage targets being identified and studied.
Drug developers in this space are actively seeking external expertise across manufacturing macrophages for human use, biomarker identification, animal models, safety and efficacy testing, in-vivo imaging, and experienced clinical research.
Partnering with the Macrophage-directed Therapies Summit will ensure you capitalize on the market share early, cement your position as an industry leader and support the growth of safe and effective macrophage-directed therapies.
This is your opportunity to:
Showcase your expertise and educate the industry on how you can support and streamline their efforts
Build new relationships via targeted networking with senior level decision makers from leading pharma and biotech organisations
Drive your brand and cement your reputation to maximize exposure and differentiate yourself from competitors
If you have relevant capabilities in this therapeutic space and would like to align your brand with this market, partner with us to promote your capabilities through a bespoke commercial package by contacting us today at email@example.com